vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in vTv Therapeutics Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +11 vs. Q1 2026
- Shares held
- 1.61M
- +119.9K (+8.1%) vs. Q1 2026
- Total value
- $60.5M
- +$1.52M (+2.6%) vs. Q1 2026
- New holders
- 17
- 6 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 3 | $0 | 0.00% | −40−93.0% | Reduced |
| Strategic Wealth Partners, Ltd. | 1 | $38 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $75 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 2 | $75 | 0.00% | +2 | New |
| Parallel Advisors, LLC | 38 | $1.43K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 45 | $1.69K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 50 | $1.88K | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 112 | $4.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 143 | $5.38K | 0.00% | +143 | New |
| State of Wyoming | 147 | $5.54K | 0.00% | +147 | New |
| Strengthening Families & Communities, LLC | 173 | $6.51K | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 283 | $10.7K | 0.00% | 00.0% | Unchanged |
| Valley National Advisers Inc | 980 | $36.9K | 0.00% | +980 | New |
| Morgan Stanley | 1,009 | $38.0K | 0.00% | −146−12.6% | Reduced |
| Advisor Group Holdings, Inc. | 1,020 | $38.4K | 0.00% | −99−8.8% | Reduced |
| Vanguard Global Advisers, LLC | 1,275 | $48.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,802 | $67.8K | 0.00% | +1,793+19,922.2% | Added |
| UBS Group AG | 2,175 | $81.9K | 0.00% | −3,461−61.4% | Reduced |
| China Universal Asset Management Co., Ltd. | 2,500 | $94.1K | 0.01% | +2,500 | New |
| Citadel Advisors LLC | 5,906 | $222.4K | 0.00% | +5,906 | New |
| HRT Financial LP | 5,923 | $223.0K | 0.00% | +5,923 | New |
| Point72 Asset Management, L.P. | 5,947 | $223.9K | 0.00% | +5,947 | New |
| Pathstone Holdings, LLC | 6,073 | $228.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 6,123 | $230.5K | 0.00% | −11,929−66.1% | Reduced |
| Trexquant Investment LP | 6,240 | $234.9K | 0.00% | +6,240 | New |
| Quadrature Capital Ltd | 6,305 | $237.4K | 0.00% | +6,305 | New |
| Susquehanna International Group, LLP | 8,023 | $302.1K | 0.00% | +8,023 | New |
| Integrated Quantitative Investments LLC | 8,210 | $309.1K | 0.05% | +8,210 | New |
| Verdad Advisers, LP | 8,996 | $338.7K | 0.32% | +8,996 | New |
| Two Sigma Investments, LP | 11,486 | $432.4K | 0.00% | +11,486 | New |
| State Street Corp | 12,266 | $461.8K | 0.00% | +1,600+15.0% | Added |
| Jane Street Group, LLC | 13,703 | $515.9K | 0.00% | +13,703 | New |
| BlackRock, Inc. | 14,731 | $554.6K | 0.00% | +2,129+16.9% | Added |
| Vanguard Fiduciary Trust Co | 16,239 | $611.4K | 0.00% | +113+0.7% | Added |
| Renaissance Technologies LLC | 17,454 | $657.1K | 0.00% | +17,454 | New |
| Geode Capital Management, LLC | 32,470 | $1.22M | 0.00% | −416−1.3% | Reduced |
| Marshall Wace, LLP | 39,560 | $1.49M | 0.00% | +26,171+195.5% | Added |
| Aisling Capital Management LP | 50,000 | $1.88M | 0.40% | +50,000 | New |
| Trails Edge Capital Partners, LP | 85,192 | $3.21M | 0.51% | −54,386−39.0% | Reduced |
| Vanguard Capital Management LLC | 94,463 | $3.56M | 0.00% | −14,459−13.3% | Reduced |
| Baker Bros. Advisors LP | 148,314 | $5.58M | 0.03% | 00.0% | Unchanged |
| Siren, L.L.C. | 163,000 | $6.14M | 0.12% | 00.0% | Unchanged |
| FMR LLC | 260,391 | $9.80M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 269,874 | $10.2M | 0.01% | +63,586+30.8% | Added |
| Samsara BioCapital, LLC | 298,496 | $11.2M | 0.92% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,350−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −7,531−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −5,618−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |